Atrovent HFA and Lenvatinib Mesylate
Determining the interaction of Atrovent HFA and Lenvatinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ipratropium
Brand name: Atrovent HFA, Atrovent
Synonyms: n.a.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Atrovent HFA-Lenvima
- Atrovent HFA-Lenvima (14 MG Daily Dose)
- Atrovent HFA-Lenvima (18 MG Daily Dose)
- Atrovent HFA-Lenvima (20 MG Daily Dose)
- Atrovent HFA-Lenvima (24 MG Daily Dose)
- Atrovent HFA-Lenvima (8 MG Daily Dose)
- Lenvatinib Mesylate-Atrovent Inhalation, oral/nebulization
- Lenvatinib Mesylate-Atrovent Nasal
- Lenvatinib Mesylate-Atrovent Nasal Spray
- Lenvatinib Mesylate-Atrovent Nasal Spray eent
- Lenvatinib Mesylate-ATryn
- Lenvatinib Mesylate-Attapulgite Liquid and Suspension